Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,154 | 18,413 | 42,056 | 18,771 | 73,873 |
| Marketable Securities | 24,929 | 59,541 | 57,150 | 104,284 | 64,098 |
| Other current assets | 4,546 | 4,908 | 4,229 | 4,889 | 5,234 |
| TOTAL | $59,629 | $82,862 | $103,435 | $127,944 | $143,205 |
| Non-Current Assets | |||||
| PPE Net | 1,590 | 1,867 | 2,035 | 2,063 | 2,214 |
| Other Non-Current Assets | 3,339 | 3,804 | 4,294 | 4,699 | 5,280 |
| TOTAL | $4,929 | $5,671 | $6,329 | $6,762 | $7,494 |
| Total Assets | $64,558 | $88,533 | $109,764 | $134,706 | $150,699 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,639 | 3,982 | 4,651 | 3,937 | 4,460 |
| Accrued Expenses | 11,989 | 13,526 | 13,605 | 12,209 | 11,001 |
| TOTAL | $23,322 | $21,233 | $21,987 | $20,265 | $18,948 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 168 | 579 | N/A |
| Other Non-Current Liabilities | 9,447 | 13,755 | 15,822 | 12,453 | 15,184 |
| TOTAL | $9,447 | $13,755 | $15,944 | $12,575 | $15,306 |
| Total Liabilities | $32,769 | $34,988 | $37,931 | $32,840 | $34,254 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,188 | 6,188 | 6,154 | 6,151 | 6,115 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -665,241 | -642,201 | -622,320 | -590,783 | -574,920 |
| Other shareholders' equity | 438 | 468 | 455 | 420 | 447 |
| TOTAL | $31,789 | $53,545 | $71,833 | $101,866 | $116,445 |
| Total Liabilities And Equity | $64,558 | $88,533 | $109,764 | $134,706 | $150,699 |